Key Takeaways
- International Business Machines shares declined more than 4% in premarket trading Thursday following Accenture’s decision to reduce its fiscal 2026 revenue outlook
- Accenture revised its full-year revenue forecast to $71.76B–$72.46B, eliminating the previous upper target of $73.16B
- While Accenture’s Q3 earnings per share of $3.80 exceeded forecasts, its quarterly sales of $18.7B fell short of the $18.745B analyst consensus
- According to GF Value analysis, IBM trades at approximately 9.9% above fair value at $262.35, carrying a GF Score of 78/100
- IBM is scheduled to release Q2 financial results on July 22; Wall Street projects EPS of $3.00 with revenue reaching $17.85B
International Business Machines experienced a significant decline Thursday morning after industry peer Accenture reduced its fiscal 2026 revenue projections, creating widespread pressure across the IT services industry.
International Business Machines Corporation, IBM
Shares of IBM were changing hands at $251.01 during premarket hours, representing a 4.32% decline. The stock had already retreated 3.1% to close at $262.35 on June 17.
The downturn wasn’t caused by any IBM-specific developments. Instead, market participants reacted negatively to Accenture’s revised financial outlook.
Accenture tightened its annual revenue projection to between $71.763 billion and $72.460 billion. This represents a reduction from the previously stated upper limit of $73.157 billion. Analysts had been anticipating $74.006 billion for the fiscal year.
This type of guidance adjustment tends to create contagion effects throughout related industry segments — with IBM experiencing the fallout.
Regarding profitability metrics, Accenture exceeded expectations. Third-quarter diluted earnings per share reached $3.80, surpassing the $3.69 analyst estimate. However, quarterly sales of $18.700 billion narrowly missed the consensus forecast of $18.745 billion, and the forward-looking guidance revision triggered the negative market response.
Accenture’s CEO Julie Sweet highlighted robust artificial intelligence demand, citing 104 client engagements valued at $100 million or higher year-to-date, representing a 13% increase. The company simultaneously disclosed intentions to purchase a majority ownership position in Dragos alongside complete acquisitions of runZero and NetRise, focusing on operational technology cybersecurity capabilities.
IBM’s Q2 Financial Release Scheduled for July 22
IBM’s quarterly financial disclosure arrives on July 22. Market analysts anticipate earnings per share of $3.00 alongside revenue of $17.85 billion for the second quarter.
During the first quarter, IBM delivered EPS of $1.91, exceeding the $1.81 projection. Sales totaled $15.92 billion, surpassing the $15.66 billion consensus estimate. This performance extended IBM’s streak of exceeding earnings expectations to eight consecutive quarters — a pattern investors will monitor closely for continuation.
Current Valuation Analysis
GuruFocus establishes IBM’s GF Value at $238.63, indicating the shares were trading at approximately a 9.9% premium relative to this intrinsic value calculation at $262.35.
IBM’s present price-to-earnings ratio of 23.2x registers marginally below its five-year median level of 24.4x. The forward-looking P/E ratio stands at 21.1x.
The company’s GF Score of 78/100 indicates above-average positioning versus industry peers, with profitability representing the most robust metric at 8/10. Financial strength registers at 5/10 while momentum scores 4/10 — the latter aligning with Thursday’s price action.
Notably, insider transaction activity has been absent throughout the preceding three-month period.
IBM’s 52-week trading range extends from $212.34 to $332.46, positioning Thursday’s premarket level of $251.01 within the lower portion of this spectrum.
The upcoming significant catalyst for IBM arrives on July 22.


